TFS’s Expertise in Oncology

TFS is Your Global Oncology CRO Partner

Looking for an experienced oncology CRO to support your clinical trial? TFS HealthScience is a global, full-service contract research organization with a strong track record in delivering successful oncology and hematology studies.

With over 300 oncology and hematology clinical trials completed in 17+ countries, TFS offers the therapeutic expertise, global reach, and operational excellence you need to accelerate your study. Our specialized operations teams and medical advisors are dedicated to advancing oncology research with cutting-edge approaches—from CAR-T and biomarker-driven studies to adaptive trial designs and radiopharmaceutical innovations.

Download the reference sheet to:

  • See our breadth of experience across key oncology and hematologic indications
  • Explore our capabilities in cell and gene therapies, immuno-oncology, and more
  • Understand how TFS supports your success from early- to late-phase trials

Download our reference sheet now to see how TFS brings scientific insight, operational precision, and global execution to oncology clinical trials.

Learn more about our related services and resources:

TFS Oncology & Hematology

Connect with Us

Contact us today to discover how TFS can be your strategic CRO partner in clinical development.

Let's Talk

Learn More About Our Oncology Expertise

The Value of Cross-Functional Expertise in Complex Oncology Clinical TrialsArticle

The Value of Cross-Functional Expertise in Complex Oncology Clinical Trials

Experienced Oncology CROs with cross-functional expertise strengthen complex oncology clinical trials and accelerates clinical development.
Customisation, partnerships and AI the keys to the future of clinical trials
From Strategy to Patients: Adaptability and Innovation in Trial DesignArticle

From Strategy to Patients: Adaptability and Innovation in Trial Design

Explore how adaptability, innovation, and patient focus can help sponsors rethink trial execution, from smarter sourcing models to the role of AI in oncology.
Insights from ASCO 2025: Oncology Clinical Trial Trends CROs and Sponsors Need to KnowArticle

Insights from ASCO 2025: Oncology Clinical Trial Trends CROs and Sponsors Need to Know

Explore key takeaways from ASCO 2025, from ctDNA and AI to novel biologics and inclusive trials. Learn how to stay ahead in oncology research.